{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:45:32Z","timestamp":1761871532217,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.clml.2021.01.023","type":"journal-article","created":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T10:20:00Z","timestamp":1612606800000},"page":"e488-e492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Determination and Role of Epstein-Barr Virus in Patients With Lymphoproliferative Disorders"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9876-935X","authenticated-orcid":false,"given":"Meryem","family":"Colak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1777-1701","authenticated-orcid":false,"given":"Shakhnoza","family":"Sarzhanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep Arzu","family":"Yegin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zubeyde Nur","family":"Ozkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isil","family":"Fidan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulendam","family":"Bozdayi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2021.01.023_bib1","first-page":"702","article-title":"Virus particles in cultured lymphoblasts from Burkett\u2019s lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clml.2021.01.023_bib2","first-page":"149","article-title":"Epstein-Barr virus infection and human malignancies","volume":"82","author":"Niedobitek","year":"2001","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.clml.2021.01.023_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.seminoncol.2014.12.030","article-title":"Epstein-barr virus\u2013associated lymphomas","volume":"42","author":"Grywalska","year":"2015","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clml.2021.01.023_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clml.2011.11.006","article-title":"Incidence of Epstein-Barr virus in pediatric leukemia in the Sudan","volume":"12","author":"Ahmed","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2021.01.023_bib5","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1098\/rstb.2016.0271","article-title":"Epstein-Barr virus\u2013associated lymphomas","volume":"372","author":"Shannon-Lowe","year":"2017","journal-title":"Phil Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.clml.2021.01.023_bib6","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/jmv.24797","article-title":"Correlations between Epstein-Barr virus and acute leukemia","volume":"89","author":"Guan","year":"2017","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.clml.2021.01.023_bib7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.4459","article-title":"The Epstein-Barr virus and the pathogenesis of lymphoma","volume":"235","author":"Vockerodt","year":"2015","journal-title":"J\u00a0Pathol Clin Res"},{"key":"10.1016\/j.clml.2021.01.023_bib8","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","article-title":"Age related EBV associated lymphoproliferative disorder\u2014a spectrum of reactive lymphoid hyperplasia and lymphoma: the Western experience","volume":"117","author":"Dojcinov","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.01.023_bib9","first-page":"882","article-title":"The prevalence of Epstein-Barr virus infection in head and neck non-Hodgkin\u2019s lymphomas in Khorasan, northeast of Iran","volume":"63","author":"Abadi","year":"2013","journal-title":"J\u00a0Pak Med Assoc"},{"key":"10.1016\/j.clml.2021.01.023_bib10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/bmt.2008.386","article-title":"Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia","volume":"43","author":"Styczynski","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2021.01.023_bib11","first-page":"594","article-title":"Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections","volume":"46","author":"Karada\u011f","year":"2012","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.clml.2021.01.023_bib12","first-page":"119","article-title":"Evaluation of enzyme-linked fluorescent assay results for determining Epstein-Barr virus serology at Ege University Hospital","volume":"53","author":"Soylu","year":"2014","journal-title":"Ege T\u0131p Derg"},{"key":"10.1016\/j.clml.2021.01.023_bib13","first-page":"10","article-title":"Utility of real-time PCR in the diagnosis of primary Epstein-Barr virus infection","volume":"2","author":"Gartzonika","year":"2012","journal-title":"J\u00a0Med Microb Diagn"},{"key":"10.1016\/j.clml.2021.01.023_bib14","doi-asserted-by":"crossref","first-page":"18653","DOI":"10.18632\/oncotarget.4418","article-title":"Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival","volume":"6","author":"Visco","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.clml.2021.01.023_bib15","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3109\/10428194.2014.938326","article-title":"Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus\u2013positive diffuse large B-cell lymphoma","volume":"56","author":"Morishima","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2021.01.023_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bbmt.2010.08.007","article-title":"Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients","volume":"17","author":"Reddy","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2021.01.023_bib17","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/MOH.0000000000000083","article-title":"Epstein-Barr virus lymphoproliferative disease after hematopoietic stem cell transplant","volume":"21","author":"Rouce","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.clml.2021.01.023_bib18","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1182\/blood-2015-05-615872","article-title":"How I treat posttransplant lymphoproliferative disorders","volume":"126","author":"Dierickx","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.01.023_bib19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.5500\/wjt.v6.i3.505","article-title":"Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders","volume":"6","author":"Morscio","year":"2016","journal-title":"World J Transplant"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021000410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021000410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:36:07Z","timestamp":1761870967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265021000410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2152265021000410"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2021.01.023","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination and Role of Epstein-Barr Virus in Patients With Lymphoproliferative Disorders","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2021.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}